Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 134241, "name": "Jagsonpal Pharma", "stock_name": "Jagsonpal Pharma", "full_name": "Jagsonpal Pharmaceuticals Ltd", "name_url": "stocks-analysis/jagsonpal-pharma", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "179.50", "chg": 10.5, "chgp": "6.21%", "dir": 1, "prev_price": "169.00", "mcapval": "1,207.00 Cr", "mcap": "Small Cap", "scripcode": 507789, "symbol": "JAGSNPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE048B01035", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "99.31 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3817978", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_mojoScore_3817978.png", "date": "2026-02-03 10:10:04", "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most recent insights into the company’s performance and outlook." }, { "title": "Jagsonpal Pharmaceuticals Ltd Opens Strong with Significant Gap Up on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3817603", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_gapup_3817603.png", "date": "2026-02-03 09:38:35", "description": "Jagsonpal Pharmaceuticals Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 5.98% higher than its previous close. This robust start outpaced the Pharmaceuticals & Biotechnology sector’s gain of 2.66%, signalling a notably positive market response amid a day that saw the stock reach an intraday high of Rs 182.6, an 8.05% increase." }, { "title": "Jagsonpal Pharmaceuticals Ltd: Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3813466", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JagsonpalPharma_valuationdot_3813466.png", "date": "2026-02-01 08:00:13", "description": "Jagsonpal Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, raising concerns about its price attractiveness relative to historical levels and peer benchmarks. Despite a recent uptick in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest investors should carefully weigh the risks amid a challenging sector backdrop." }, { "title": "Jagsonpal Pharmaceuticals Falls 7.04%: 5 Key Factors Behind the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-falls-704-5-key-factors-behind-the-weekly-decline-3804299", "imagepath": "", "date": "2026-01-25 16:00:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>19 Jan:</strong> New 52-week low at Rs.174.5</p>\n <p><strong>20 Jan:</strong> Further 52-week low at Rs.168.7</p>\n <p><strong>21 Jan:</strong> Sharp drop to Rs.165, marking continued weakness</p>\n <p><strong>22 Jan:</strong> Fresh 52-week low at Rs.158.5 amid six-day losing streak</p>\n <p><strong>23 Jan:</strong> Week closes at Rs.163.80, down 0.70% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.176.20</div></div>\n <div class=\"stat-item\"><div class=..." }, { "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-3801520", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JagsonpalPharma_mojoScore_3801520.png", "date": "2026-01-23 10:10:03", "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.158.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1585-3800056", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JagsonpalPharma_priceRelatedfactors_3800056.png", "date": "2026-01-22 10:38:45", "description": "Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.158.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry." }, { "title": "Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.165", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-falls-to-52-week-low-of-rs165-3798404", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JagsonpalPharma_priceRelatedfactors_3798404.png", "date": "2026-01-21 10:55:56", "description": "Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.165 today, marking a significant decline amid broader market pressures and company-specific valuation concerns. The stock has underperformed its sector and benchmark indices, reflecting a challenging period for the pharmaceutical firm." }, { "title": "Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.168.7", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1687-3796051", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JagsonpalPharma_priceRelatedfactors_3796051.png", "date": "2026-01-20 10:18:37", "description": "Jagsonpal Pharmaceuticals Ltd’s stock declined to a fresh 52-week low of Rs.168.7 on 20 Jan 2026, marking a significant downturn amid a broader market pullback. The stock has underperformed its sector and benchmark indices, reflecting ongoing valuation concerns despite recent profit growth." }, { "title": "Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.174.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1745-3794161", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JagsonpalPharma_priceRelatedfactors_3794161.png", "date": "2026-01-19 09:44:24", "description": "Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.174.5 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific valuation concerns." } ], "total": 226, "sid": "134241", "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "27-Jan-2026", "details": "Earnings Call Transcript for meeting held on 22 January 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "22-Jan-2026", "details": "In continuation to our earlier intimation dated January 15 2026 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the audio recording of the Jagsonpal Pharmaceuticals Limited Q3 FY26 Earnings Conference Call held on January 22 2026 at 5:00 P.M. for discussion of Q3 FY26 Financial Results is available on the Companys website at below link: https://www.jagsonpal.com/investor-relations/earning-calls. We request you to take the above on record.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "22-Jan-2026", "details": "Pursuant to Regulation 47 of SEBI (LODR) 2015 please find enclosed copies of advertisement published on January 22 2026 in Business Standard (English) and Business Standard (Hindi) newspaper providing extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25", "dt": "2025-01-08", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

19 Jan: New 52-week low at Rs.174.5

20 Jan: Further 52-week low at Rs.168.7

21 Jan: Sharp drop to Rs.165, marking continued weakness

22 Jan: Fresh 52-week low at Rs.158.5 amid six-day losing streak

23 Jan: Week closes at Rs.163.80, down 0.70% on the day

Week Open

Rs.176.20

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-01-23 10:10:03

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.158.5

2026-01-22 10:38:45

Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.158.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.

Read full news article

Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.165

2026-01-21 10:55:56

Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.165 today, marking a significant decline amid broader market pressures and company-specific valuation concerns. The stock has underperformed its sector and benchmark indices, reflecting a challenging period for the pharmaceutical firm.

Read full news article

Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.168.7

2026-01-20 10:18:37

Jagsonpal Pharmaceuticals Ltd’s stock declined to a fresh 52-week low of Rs.168.7 on 20 Jan 2026, marking a significant downturn amid a broader market pullback. The stock has underperformed its sector and benchmark indices, reflecting ongoing valuation concerns despite recent profit growth.

Read full news article

Jagsonpal Pharmaceuticals Ltd Falls to 52-Week Low of Rs.174.5

2026-01-19 09:44:24

Jagsonpal Pharmaceuticals Ltd has touched a new 52-week low of Rs.174.5 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific valuation concerns.

Read full news article